395 related articles for article (PubMed ID: 28364811)
1. Treatment Options in Patients Awaiting Liver Transplantation with Hepatocellular Carcinoma and Cholangiocarcinoma.
Unzueta A; Cabrera R
Clin Liver Dis; 2017 May; 21(2):231-251. PubMed ID: 28364811
[TBL] [Abstract][Full Text] [Related]
2. Response to Loco-Regional Therapy Predicts Outcomes After Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma.
Antwi SO; Habboush YY; Chase LA; Lee DD; Patel T
Ann Hepatol; 2018 Oct; 17(6):969-979. PubMed ID: 30600299
[TBL] [Abstract][Full Text] [Related]
3. Synchronous occurrence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in both lobes of the liver.
Topaloğlu S; Sağlam K; Çalık A; Cobanoğlu Ü; Öztürk MH
Turk J Gastroenterol; 2014 Apr; 25(2):209-11. PubMed ID: 25003684
[TBL] [Abstract][Full Text] [Related]
4. The mRECIST Classification Provides Insight into Tumor Biology for Patients With Hepatocellular Carcinoma Awaiting Liver Transplantation.
Lee DD; Samoylova M; Mehta N; Musto KR; Roberts JP; Yao FY; Harnois DM
Liver Transpl; 2019 Feb; 25(2):228-241. PubMed ID: 30198150
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma and cholangiocarcinoma: an update.
Yazici C; Niemeyer DJ; Iannitti DA; Russo MW
Expert Rev Gastroenterol Hepatol; 2014 Jan; 8(1):63-82. PubMed ID: 24245910
[TBL] [Abstract][Full Text] [Related]
6. Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis.
Kulik L; Heimbach JK; Zaiem F; Almasri J; Prokop LJ; Wang Z; Murad MH; Mohammed K
Hepatology; 2018 Jan; 67(1):381-400. PubMed ID: 28859222
[TBL] [Abstract][Full Text] [Related]
7. Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation.
Pompili M; Francica G; Ponziani FR; Iezzi R; Avolio AW
World J Gastroenterol; 2013 Nov; 19(43):7515-30. PubMed ID: 24282343
[TBL] [Abstract][Full Text] [Related]
8. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N
J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428
[TBL] [Abstract][Full Text] [Related]
9. [Primary Liver Cancers - Hepatocellular Carcinoma and Cholangiocarcinoma].
Soysal SD; Kollmar O
Ther Umsch; 2021; 78(10):585-588. PubMed ID: 34844438
[TBL] [Abstract][Full Text] [Related]
10. [Regional therapy of liver tumors].
Spangenberg HC; Mohr L; Blum HE
Internist (Berl); 2007 Jan; 48(1):40-5. PubMed ID: 17160664
[TBL] [Abstract][Full Text] [Related]
11. Bridging to liver transplantation in HCC patients.
Kollmann D; Selzner N; Selzner M
Langenbecks Arch Surg; 2017 Sep; 402(6):863-871. PubMed ID: 28755240
[TBL] [Abstract][Full Text] [Related]
12. Hepatobiliary tumours.
Simcock R
Practitioner; 2001 Aug; 245(1625):668-74. PubMed ID: 11524939
[No Abstract] [Full Text] [Related]
13. Photodynamic therapy provides local control of cholangiocarcinoma in patients awaiting liver transplantation.
Cosgrove ND; Al-Osaimi AM; Sanoff HK; Morris MM; Read PW; Cox DG; Mann JA; Argo CK; Berg CL; Pelletier SJ; Maluf DG; Wang AY
Am J Transplant; 2014 Feb; 14(2):466-71. PubMed ID: 24373228
[TBL] [Abstract][Full Text] [Related]
14. Mixed hepatocellular carcinoma and cholangiocarcinoma treated by extended left hepatic lobectomy with resection of the right hepatic vein and preservation of the inferior right hepatic vein after hepatic arterial infusion chemotherapy.
Hanazaki K; Fujimori Y; Kajikawa S; Nakata S; Shimozawa N; Adachi W; Amano J
Hepatogastroenterology; 1998; 45(21):812-5. PubMed ID: 9684139
[TBL] [Abstract][Full Text] [Related]
15. [Indications for transplantation and bridging procedures for primary hepatobiliary malignancies].
Mittler J; Heinrich S; Lang H
Chirurg; 2018 Nov; 89(11):865-871. PubMed ID: 30238348
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate.
Cescon M; Cucchetti A; Ravaioli M; Pinna AD
J Hepatol; 2013 Mar; 58(3):609-18. PubMed ID: 23041304
[TBL] [Abstract][Full Text] [Related]
17. Liver Transplant for Cholangiocarcinoma.
Zamora-Valdes D; Heimbach JK
Gastroenterol Clin North Am; 2018 Jun; 47(2):267-280. PubMed ID: 29735023
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic approach to hepatocellular carcinoma: a difficult choice.
Gennari L
Ann Ital Chir; 2008; 79(2):79-80. PubMed ID: 18727268
[TBL] [Abstract][Full Text] [Related]
19. Can the Limits of Liver Transplantation Be Expanded in Perihilar Cholangiocarcinoma?
Yilmaz S; Carr BI; Akbulut S
J Gastrointest Cancer; 2022 Dec; 53(4):1104-1112. PubMed ID: 34738188
[TBL] [Abstract][Full Text] [Related]
20. Impact of neoadjuvant chemoradiation on the tumor burden before liver transplantation for unresectable cholangiocarcinoma.
Panjala C; Nguyen JH; Al-Hajjaj AN; Rosser BA; Nakhleh RE; Bridges MD; Ko SJ; Buskirk SJ; Kim GP; Harnois DM
Liver Transpl; 2012 May; 18(5):594-601. PubMed ID: 22140024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
